Skip to main content
Clinical Trials/NCT01602991
NCT01602991
Withdrawn
Not Applicable

Sensitivity, Specificity, and Positive and Negative Predictive Values of Clinic-based Nasopharyngoesophagogastroscopy Following Bariatric Surgery

Dennis Hong MD1 site in 1 countryMay 2012
ConditionsObesity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
Dennis Hong MD
Locations
1
Primary Endpoint
Sensitivity, specificity, and positive and negative predictive values of in-office transnasal esophagoscopy in evaluating symptomatic, post-operative bariatric surgery patients.
Status
Withdrawn
Last Updated
10 years ago

Overview

Brief Summary

This study aims to determine that this new technology, nasopharyngoendoscopy, is just as effective in diagnosing problems as the current gold standard.

Detailed Description

Obesity is a public health problem. Currently, the best treatment is surgery. However, 15% of patients after surgery have problems such as nausea, pain, vomiting, heartburn or regurgitation. To investigate these problems, an endoscopy is used. Yet, endoscopy has some disadvantages such as the need for intravenous sedation, need to take time off work, need for special endoscopy units and nurses and a delay in diagnosing because the endoscopy cannot be done at the time of the clinic visit. A new technology called clinic-based nasopharyngoendoscopy can potentially solve many of the problems with the current endoscopy. This study aims to determine that this new technology is just as effective in diagnosing problems as the current gold standard.

Registry
clinicaltrials.gov
Start Date
May 2012
End Date
May 2013
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Dennis Hong MD
Responsible Party
Sponsor Investigator
Principal Investigator

Dennis Hong MD

PI

McMaster University

Eligibility Criteria

Inclusion Criteria

  • Post-operative gastric bypass patients at St. Joseph's Healthcare Hamilton
  • No previous nasal or pharyngeal surgery
  • Foregut dyspeptic symptoms including: nausea, vomiting, regurgitation, epigastric pain, reflux and/or hematemesis
  • Require endoscopy for investigation of foregut symptoms
  • Able to provide consent

Exclusion Criteria

  • Patients who have not undergone gastric bypass surgery
  • Inability to give consent

Outcomes

Primary Outcomes

Sensitivity, specificity, and positive and negative predictive values of in-office transnasal esophagoscopy in evaluating symptomatic, post-operative bariatric surgery patients.

Time Frame: Approximately 8 weeks

The patients will receive transnasal esophagoscopy, then standard endoscopy approximately 2 weeks later. Patients will return to the bariatric clinic 2-4 weeks after standard endoscopy to review the results of both procedures and discuss possible treatment. Patients will not be required to undergo any further study-related follow-up or complete any questionnaires.

Secondary Outcomes

  • Complications of standard and in-office transnasal esophagoscopy(approximately 8 weeks)
  • How well patients tolerate in-office transnasal esophagoscopy(Immediately following transnasal esophagoscopy)
  • Differences in in-hospital resource use between standard endoscopy and office-based transnasal nasopharyngoendoscopy(Approximately 8 weeks)

Study Sites (1)

Loading locations...

Similar Trials